Skip to main content
. 2024 Apr 18;22(2):qzae033. doi: 10.1093/gpbjnl/qzae033

Figure 5 .


Figure 5

The atlas of potential drug targets for individual patients in S-III

FC, fold change; UPS, ubiquitin–proteasome system.